1. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): Policy Statement. Geneva, World Health Organization, 27 June 2008; Available: http://www.who.int/tb/features_archive/policy_statement.pdf. Accessed7 February 2014.
2. Rapid implementation of the Xpert MTB/RIF diagnostic test. WHO/HTM/TB/2011.2. Geneva, World Health Organization, 2011. Available: http://whqlibdoc.who.int/publications/2011/9789241501569_eng.pdf. Accessed 7 February 2014.
3. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update;S Ramaswamy;Tuber Lung Dis,1998
4. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis;A Telenti;Lancet,1993
5. Guidelines for surveillance of drug resistance in tuberculosis. Geneva, World Health Organization, 1994, (document WHO/TB/94.178). Available: http://who.int/tb/publications/1994/en/index.html. Accessed7 February 2014.